CAS: 66251-18-1; (1R,3Ar,7Ar)-1-[(1R)-1,5-Dimethylhexyl]Octahydro-7A-Methyl-4H-Inden-4-One

该化合物是一个复杂的有机化合物,其特点是具有双环结构,包括六氢氰化物核心,具有多个手性中心,有助于其立体化学复杂性和异构学潜力,由于结构内存在碳基组(C=O),通常被归类为酮类,如六甲基乙烷-2-yl组等烷基子体的存在表明,它可能具有疏水特性,使其在极地溶剂中不易溶解,其独特结构可能给诸如芳香化学或合成有机化学的潜在前体等领域带来具体的生物活动或应用.该化合物的稳定性,再活性和与其他物质的相互作用取决于其功能组和整体分子几何,这对于了解其在各种化学环境中的行为至关重要.

结构式图片

相似化合物

33813-99-9 124905-24-4 83076-51-1

合成工艺路线路线简述

    📜维生素 D3置于吡啶,碳酸氢钠,戴斯-马丁氧化剂,臭氧体系中,用 甲醇,二氯甲烷 作为反应溶剂,化学反应 19.5H,反应生成 艾地骨化醇中间体
    参考文献:1α,25-二羟基-2β-(3-羟基丙氧基)维生素d 3(ed-71)的全合成
    标题:1α,25-二羟基-2β-(3-羟基丙氧基)维生素d 3(ed-71)的全合成
    摘要:已经开发了用于合成ed-71的收敛方法.从所报道的易于制备d-甘露醇的环氧化物5开始,Ed-71以11个线性步骤合成,总收率为17%.
    DOI:10.1016/j.Tet.2020.131081

    海关参考信息

    专利信息


    专利号:US-5292977-A
    优先权日:1992-02-05
    标题:Palladium catalyzed alkylative cyclization useful in synthesis of vitamin D and analogues
    发明人:TROST BARRY M; DUMAS JACQUES
    权利人:UNIV LELAND STANFORD JUNIOR
    摘要:An alkylative cycloaddition method is provided that is particularly useful for the synthesis of many of the Vitamin D analogues with differing side chains. Thus, a preferred synthesis is of Vitamin D analogues having a side chain R 1 where a substantially geometrically pure first precursor having the structure ##STR1## and a second precursor are provided, the second precursor being a 1,7 enyne. These precursors are reacted in the presence of a palladium catalyst to form compounds having the structure ##STR2## where R 2 hydrogen, hydroxyl, lower alkoxy, fluorine, or a protecting group, and R 3 is hydrogen, hydroxyl, lower alkoxy, fluorine, or a protecting group.

    专利号:US-5446225-A
    优先权日:1992-02-05
    标题:Palladium catalyzed akylative cyclization useful in syntheses of Vitamin D and analogues
    发明人:TROST BARRY M; DUMAS JACQUES
    权利人:UNIV LELAND STANFORD JUNIOR
    摘要:An alkylative cycloaddition method is provided that is particularly useful for the synthesis of many of the Vitamin D analogues with differing side chains. Thus, a preferred synthesis is of Vitamin D analogues having a side chain R 1 where a first precursor having the structure ##STR1## with X being a halide or a pseudo halide, and a second precursor are provided, the second precursor being a 1,7 enyne. These precursors are reacted in the presence of a palladium catalyst to form compounds having the structure ##STR2## where R 2 is hydrogen, hydroxyl, lower alkoxy, fluorine, or a protecting group, and R 3 is hydrogen, hydroxyl, lower alkoxy, fluorine, or a protecting group.

    专利号:EP-1494680-B1
    优先权日:2002-03-25
    标题 :Use of carbon-2-modified-vitamin d analogs to induce the formation of new bone
    发明人:DELUCA HECTOR F; PIKE J WESLEY; SHEVDE NIRUPAMA K
    权利人:WISCONSIN ALUMNI RES FOUND
    摘要:It has been discovered that the 2-carbon-modified derivatives of 1α,25-dihydroxyvitamin D3 specifically stimulate osteoblasts to form new bone. The ability of the 2-carbon-modified vitamin D analogs to stimulate new bone formation suggest that these compounds can be used where synthesis of new bone is required. Thus, these compounds can be used either systemically or locally to stimulate the growth of bone transplants, to increase the rate of fracture healing and thereby reduce the time required for the healing of fractures, the stimulation of bone growth when required for replacement surgery, and also for the growth of bone to implants or other devices required to maintain the skeleton or teeth in the proper positions.

    专利号:CA-2561590-C
    优先权日:2004-04-02
    标题 :Novel method for the preparation of intermediates useful for the synthesis of vitamin d analogues

    专利号:WO-2005095336-A2
    优先权日:2004-04-02
    标 题 :Novel method for the preparation of intermediates useful for the synthesis of vitamin d analogues

    专利号:EP-1735276-A2
    优先权日:2004-04-02
    标题:Novel method for the preparation of intermediates useful for the synthesis of vitamin d analogues

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1016/j.bmcl.2012.05.037
    摘要:DeBerardinis AM, Banerjee U, Miller M, Lemieux S, Hadden MK. Probing the structural requirements for vitamin D3 inhibition of the hedgehog signaling pathway. Bioorganic & Medicinal Chemistry Letters. 2012 Jul;22(14):4859–63. doi: 10.1016/j.bmcl.2012.05.037.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知